AKT1 and ovarian cancer: Consistent with our findings, lactate production was inhibited by blocking AKT1/GSK3β (glycogen synthase kinase 3 beta) signaling in ovarian cancer cells after treatment with the VEGFR2 kinase inhibitor apatinib [22].